Zomedica annual operating margin
2021
2022
2023
2024
2025
Zomedica's operating margin was −263.36% for fiscal 2025.
View full Zomedica company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −263.36% | −76.25 pp |
| 2024 | 2024-12-31 | −187.11% | −15.29 pp |
| 2023 | 2023-12-31 | −171.82% | −56.01 pp |
| 2022 | 2022-12-31 | −115.81% | +401.34 pp |
| 2021 | 2021-12-31 | −517.15% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −42.92% | +72.45 pp |
| Q1 2026 | 2026-03-31 | −55.69% | +937.36 pp |
| Q4 2025 | 2025-12-31 | −49.32% | +54.04 pp |
| Q3 2025 | 2025-09-30 | −81.61% | +24.73 pp |
| Q2 2025 | 2025-06-30 | −115.38% | +293.48 pp |
| Q1 2025 | 2025-03-31 | −993.05% | −827.19 pp |
| Q4 2024 | 2024-12-31 | −103.36% | +211.12 pp |
| Q3 2024 | 2024-09-30 | −106.33% | −12.62 pp |
| Q2 2024 | 2024-06-30 | −408.86% | −296.86 pp |
| Q1 2024 | 2024-03-31 | −165.86% | −28.83 pp |
| Q4 2023 | 2023-12-31 | −314.47% | −231.04 pp |
| Q3 2023 | 2023-09-30 | −93.71% | +44.31 pp |
| Q2 2023 | 2023-06-30 | −111.99% | +26.49 pp |
| Q1 2023 | 2023-03-31 | −137.03% | −22.02 pp |
| Q4 2022 | 2022-12-31 | −83.43% | +57.87 pp |
| Q3 2022 | 2022-09-30 | −138.02% | +27722.85 pp |
| Q2 2022 | 2022-06-30 | −138.48% | +33167.77 pp |
| Q1 2022 | 2022-03-31 | −115.01% | +27542.13 pp |
| Q4 2021 | 2021-12-31 | −141.30% | — |
| Q3 2021 | 2021-09-30 | −27,860.87% | — |
| Q2 2021 | 2021-06-30 | −33,306.25% | — |
| Q1 2021 | 2021-03-31 | −27,657.14% | — |
Across the available reported history, Zomedica's operating margin decreased from −187.11% to −263.36%, a change of −76.25 percentage points. The latest reported quarter, Q2 2026, shows −42.92%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Zomedica filings at SEC.gov ↗